alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 2036 Considered and Passed Senate (CPS)]

114th CONGRESS
  1st Session
                                S. 2036

 To suspend the current compensation packages for the chief executive 
    officers of Fannie Mae and Freddie Mac, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 15, 2015

Mr. Vitter (for himself and Ms. Warren) introduced the following bill; 
   which was read twice, considered, read the third time, and passed

_______________________________________________________________________

                                 A BILL

 
 To suspend the current compensation packages for the chief executive 
    officers of Fannie Mae and Freddie Mac, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Equity in Government Compensation 
Act of 2015''.

SEC. 2. DEFINITIONS.

    In this Act:
            (1) Director.--The term ``Director'' means the Director of 
        the Federal Housing Finance Agency.
            (2) Enterprise.--The term ``enterprise'' means--
                    (A) the Federal National Mortgage Association and 
                any affiliate thereof; and
                    (B) the Federal Home Loan Mortgage Corporation and 
                any affiliate thereof.

SEC. 3. REASONABLE PAY FOR CHIEF EXECUTIVE OFFICERS.

    (a) Suspension of Current Compensation Package and Limitation.--The 
Director shall suspend the compensation packages approved for 2015 for 
the chief executive officers of each enterprise and, in lieu of such 
packages, subject to the limitation under subsection (b), establish the 
compensation and benefits for each such chief executive officer at the 
same level in effect for such officer as of January 1, 2015, and such 
compensation and benefits may not thereafter be increased.
    (b) Limitation on Bonuses.--Subsection (a) shall not be construed 
to affect the applicability of section 16 of the STOCK Act (12 U.S.C. 
4518a) to the chief executive officer of each enterprise.
    (c) Applicability.--Subsection (a) shall only apply to a chief 
executive officer of an enterprise if the enterprise is in 
conservatorship or receivership pursuant to section 1367 of the Federal 
Housing Enterprises Financial Safety and Soundness Act of 1992 (12 
U.S.C. 4617).

SEC. 4. FANNIE AND FREDDIE CHIEF EXECUTIVE OFFICERS NOT FEDERAL 
              EMPLOYEES.

    Any chief executive officer affected by any provision under section 
3 shall not be considered a Federal employee.
                                 <all>
```
Exhibit 99.1

                     CERTIFICATION PURSUANT TO
                       18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
             SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report on Form 10-Q of J
Net Enterprises, Inc. (the "Company") for the quarter ended
September 30, 2002 as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Allan R.
Tessler, Chairman and Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. SS 1350, as adopted pursuant to SS 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully complies with the requirements of section 13(a)
         or 15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
         material respects, the financial condition and result of
         operations of the Company.

Dated:  November 14, 2002    By: /s/ Allan R. Tessler
                                 ____________________
                                 Allan R. Tessler
                                 Chairman and Chief Executive Officer

     This certification accompanies this Quarterly Report on Form 10-Q
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not,
except to the extent required by such Act, be deemed filed by the Company
for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended.
\\NY-srv01\848235v01\10/30/02
<PAGE>


                                                                      EXHIBIT 32
                                                                      ----------



            WINTHROP RESIDENTIAL ASSOCIATES I, A LIMITED PARTNERSHIP
            --------------------------------------------------------
                         FORM 10-QSB SEPTEMBER 30, 2003
                         ------------------------------


                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Winthrop Residential
Associates I, A Limited Partnership, (the "Partnership"), on Form 10-QSB or the
quarterly period ended September 30, 2003, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), the undersigned, in the
capacities and on the date indicated below, hereby certifies pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that: (1) the Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and (2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Partnership.



Date: November 12, 2003                        /s/ Michael L. Ashner
                                               -------------------------------
                                               Michael L. Ashner
                                               Chief Executive Officer



Date: November 12, 2003                        /s/ Thomas C. Staples
                                               -------------------------------
                                               Thomas C. Staples
                                               Chief Financial Officer












                                    18 of 19
-· 

'• 

.. .. - ~ .... ~ 

REF ID:A65552 

~-

WAR DEPARTMENT GENERAL STAFF 

DISPOSITION FORM 

Subject: Clearance on Communication Secrecy Systems 

TO Chief S1gnal Officer FROM A.C. of S., G-2 12 Mar 45 

Transmitted herewith for your information is a copy of the 

2nd indorsement of this Division to memorandum to CSO from CG, 

AAF, dated 23 February 1945, subject as above. 

3 Incls 

1. 2nd Ind (copy) 

2. lat Ind (copy) 3. Memo to CSO fr AAF (copy) 

COPY 

--r f 

, 

i.~... .... 

' I ..... .; "" • ._• 

.. .. t .. -

-, 

~· . 

CLAYTON BISSELL 

Major General, GSC 

Assistant Chief of Staff, G-2 

/s/ John Weckerling JOHN 'WECKERLING 

Brigadier General, GSC 

Deputy A.C. of s., G-2 

, 

~~ \

--,;:' ., 

I' 

("' , 

\ " 

' 

- ~ 

-· 

- • I 
• 2nd Ind • 

G-2, W. D. G. S., w~shington, D. C. 12 March 1945 

TO: The Commanding General, Army Air Forces, w~r Department, Washington, D. C. 

l. The Assistant Chief of Staff, G-2 concurs in basic 

communication and lst indorsement thereto subject to the condition that paragraph 2p. AR 105-5, 1 December 1942, is adhered 

to strictly in respect to all matters relating to the research, 

development, procurement and distribution of cryptographic material. In order that cryptographic security may ee 

adequately safeguarded, it is essential that responsibilities for research, development, procurement and distribution of 

cryptograpbic devices for use in the Army be centered in and 

discharged by a single agency. The War Department agency charged with such responsibili,ties is the Signal Security 

Agency.' 

' 2. The Chief Signal Officer has been informed with 

respect to the above. 

CLAYTON BISSELL 

Major General, GCS 

Assistant Chief of Staff, G-2 

cc: Chief Signal Officer 

c 

0 

p 

y 

--= - ri.... r ... ... P t" "'~ I II I I
<PAGE>

                                                                    EXHIBIT 21.1

                  SUBSIDIARIES OF HOLLYWOOD CASINO CORPORATION

<TABLE>
<CAPTION>
                                                         STATE
         NAME                            ADDRESS       ORGANIZED
<S>                                  <C>                <C>

Hollywood Casino - Aurora, Inc.      13455 Noel Road    Illinois
                                     Suite 2200, LB48
                                     Dallas, TX  75240

HWCC-Aurora Management, Inc.         13455 Noel Road    Illinois
                                     Suite 2200, LB48
                                     Dallas, TX  75240

HWCC - Tunica, Inc.                  13455 Noel Road    Texas
                                     Suite 2200, LB48
                                     Dallas, TX 75240

HWCC Development Corp.               13455 Noel Road    Texas
                                     Suite 2200, LB48
                                     Dallas, TX 75240

HWCC - Louisiana, Inc.               13455 Noel Road    Louisiana
                                     Suite 2200, LB48
                                     Dallas, TX  75240

HWCC - Argentina, Inc.               13455 Noel Road    Texas
                                     Suite 2200, LB48
                                     Dallas, TX  75240

Hollywood Management, Inc.           13455 Noel Road    Texas
                                     Suite 2200, LB48
                                     Dallas, TX  75240

HWCC - Golf Course Partners, Inc.    13455 Noel Road    Delaware
                                     Suite 2200, LB48
                                     Dallas, TX  75240

HWCC - Aviation, Inc.                13455 Noel Road    Texas
                                     Suite 2200, LB48
                                     Dallas, TX  75240
</TABLE>
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 1906 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
                                S. 1906

 To clarify the exclusion of orphan drug sales from the calculation of 
the annual fee on branded prescription pharmaceutical manufacturers and 
                   importers, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 30, 2015

Mr. Menendez (for himself and Mr. Crapo) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To clarify the exclusion of orphan drug sales from the calculation of 
the annual fee on branded prescription pharmaceutical manufacturers and 
                   importers, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Orphan Drug Fairness Act''.

SEC. 2. EXCLUSION OF ORPHAN DRUG SALES.

    (a) In General.--Paragraph (3) of section 9008(e) of the Patient 
Protection and Affordable Care Act (26 U.S.C. 4001 note prec.; Public 
Law 111-148) is amended to read as follows:
            ``(3) Exclusion of orphan drug sales.--The term `branded 
        prescription drug sales' shall not include sales of any drug or 
        biological product with respect to which a credit was allowable 
        for any taxable year under section 45C of the Internal Revenue 
        Code of 1986, regardless of whether such credit was claimed and 
        received. The preceding sentence shall not apply with respect 
        to any such drug or biological product after the date on which 
        such drug or biological product is approved by the Food and 
        Drug Administration for marketing for any indication other than 
        the treatment of the rare disease or condition with respect to 
        which such credit was allowable.''.
    (b) Effective Date.--The amendment made by subsection (a) shall 
take effect as if included in section 9008 of the Patient Protection 
and Affordable Care Act (26 U.S.C. 4001 note prec.; Public Law 111-
148).
                                 <all>
```
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                          27,731
<SECURITIES>                                         0
<RECEIVABLES>                                    6,596
<ALLOWANCES>                                         0
<INVENTORY>                                     13,864
<CURRENT-ASSETS>                                49,483
<PP&E>                                          25,255
<DEPRECIATION>                                   5,740
<TOTAL-ASSETS>                                 136,667
<CURRENT-LIABILITIES>                           12,194
<BONDS>                                         75,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           840
<OTHER-SE>                                      43,270
<TOTAL-LIABILITY-AND-EQUITY>                   136,667
<SALES>                                         38,523
<TOTAL-REVENUES>                                38,523
<CGS>                                           26,282
<TOTAL-COSTS>                                   33,073
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,977
<INCOME-PRETAX>                                  2,773
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              2,773
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  5,005
<CHANGES>                                            0
<NET-INCOME>                                   (2,232)
<EPS-PRIMARY>                                    (.27)
<EPS-DILUTED>                                    (.27)
        

</TABLE>
### SAT Report PMN Number: P-13-0168 SAT Date: 12/21/2012

Print Date: 5/1/2013

Related cases : Health related cases : Ecotox related cases:

Concern levels : Type of Concern: Health Eco Comments Level of Concern: 1-2 3

Persistence Bioaccum Toxicity Comments 1 21

Exposure Based Review : Health: Ecotox: N o
Routes of exposure : Health: Dermal Inhalation Ecotox: All releases to water Fate: ; Keywords : Keywords: SENS-S,L; DEVEL (UNCERT); AQUATOX
Summary of Assessment :

Fate : Fate Summary: P-13-0168 FATE: Liquid with MP < 5 C (E) log Kow = 7.39 (E) S = 0.143 mg/L at 25 C (E) VP = 2.9E-5 torr at 25 C (E) BP = 354 C (E) H = 3.38E-5 (E) log Koc = 5.32 (E) log Fish BCF = 3.34 (E)log Fish BAF = 3.74 (E) POTW removal (%) = 90 via sorption, stripping, and biodeg Time for complete ultimate aerobic biodeg = da-wk Sorption to soils/sediments = strong Volatilization half-life from a standard river = 30 hrs Volatilization half-life from a standard lake = 19 da Atmospheric Oxidation Half-life = 2.3 hr via OH radical PBT Potential: P1B2 *CEB FATE: Migration to ground water = negl

Health : Health Summary: Expect poor absorption via all routes (analog). Concern for dermal and respiratory sensitization by analogy to . Uncertain concern for developmental toxicity based on phenols.

Ecotox :
Test Organism Test Type Test End Point Predicted Measured Comments

fish 96-h LC50 0.004 daphnid 48-h LC50 0.012 green algal 96-h EC50 0.033 fish

_ chronic value 0.001 daphnid

_ chronic value 0.002

algal

_ chronic value 0.014
Sewage Sludge 3-h EC50

_ Sewage Sludge

_ Chronic Value _

Ecotox Values Comments: Predictions are based on SARs for phenols; SAR class = p henol; MW 262; log Kow = 7.39 (EPI); S = 0.14 mg/L at 20 C (P); p H7; liquid with mp unknown (P); effective concentrations based on 100% active ingredients and nominal concentrations; hardness <150.0 mg/L as CaCO3; and TOC <2.0 mg/L;

Factors Values Comments Assessment Factor 10 Concentration of Concern ( p pb) 1

SARs p henols SAR Class p henol Ecotox Category Phenols

Ecotox Factors Comments:SAT Chair: L Keifer 564-8916
# CE2004084EN.01069701.xml

| 3.4.2004 | EN | Official Journal of the European Union | CE 84/697 |
| --- | --- | --- | --- |

3.4.2004

EN

Official Journal of the European Union

CE 84/697

---

(2004/C 84 E/0784)

WRITTEN QUESTION P-0934/04

by Mogens Camre (UEN) to the Commission

(22 March 2004)

Subject:   Breakdown of EU staff by grades A, B, C and D

Subject:

In 2003, funds were allocated from the EU budget for a total of 31 000 permanent posts and 1 966 temporary posts in the EU's institutions.

Broken down by institution, the figures are as follows:

| | Permanent posts | Temporary posts |
| --- | --- | --- |
| Commission | 21 849 | 685 |
| Parliament | 4 170 | 790 |
| Council | 2866 | 53 |
| Court of Justice | 862 | 278 |
| Court of Auditors | 509 | 279 |
| Economic and Social Committee | 501 | 24 |
| Committee of the Regions | 230 | 22 |
| Ombudsman | 13 | 18 |

Permanent posts

Temporary posts

Commission

21 849

685

Parliament

4 170

790

Council

2866

53

Court of Justice

862

278

Court of Auditors

509

279

Economic and Social Committee

501

24

Committee of the Regions

230

22

Ombudsman

13

18

Will the Commission provide a breakdown of the total number of staff in each grade (A, B, C and D) by nationality within the EU?

Answer given by Mr Kinnock on behalf of the Commission

(19 April 2004)

(19 April 2004)

As at 31 December 2003, the total number of permanent and temporary staff employed by the Commission was 21 166. The breakdown of officials per category as defined in the Staff Regulations, and by nationality of origin was as follows:

| Country | A | LA | Β | c | D | Total |
| --- | --- | --- | --- | --- | --- | --- |
| Belgium | 946 | 178 | 1 322 | 2 315 | 256 | 5 017 |
| Denmark | 203 | 117 | 87 | 136 | 8 | 551 |
| Germany | 1 006 | 195 | 337 | 442 | 10 | 1 990 |
| Greece | 439 | 125 | 136 | 214 | 30 | 944 |
| Spain | 817 | 171 | 389 | 365 | 46 | 1 788 |
| France | 1 225 | 110 | 469 | 627 | 55 | 2 486 |
| Ireland | 226 | 20 | 117 | 197 | 7 | 567 |
| Italy | 1 005 | 167 | 567 | 827 | 208 | 2 774 |
| Luxembourg | 44 | 8 | 69 | 172 | 36 | 329 |
| Netherlands | 362 | 64 | 184 | 137 | 8 | 755 |
| Austria | 219 | 15 | 97 | 89 | 10 | 430 |
| Portugal | 289 | 125 | 128 | 201 | 28 | 771 |
| Finland | 215 | 112 | 144 | 120 | 7 | 598 |
| Sweden | 261 | 96 | 116 | 120 | 5 | 598 |
| United Kingdom | 773 | 173 | 248 | 288 | 9 | 1491 |
| Others | 15 | 48 | 4 | 9 | 1 | 77 |
| Total | 8 045 | 1 724 | 4 414 | 6 259 | 724 | 21 166 |

Country

A

LA

Β

c

D

Total

Belgium

946

178

1 322

2 315

256

5 017

Denmark

203

117

87

136

8

551

Germany

1 006

195

337

442

10

1 990

Greece

439

125

136

214

30

944

Spain

817

171

389

365

46

1 788

France

1 225

110

469

627

55

2 486

Ireland

226

20

117

197

7

567

Italy

1 005

167

567

827

208

2 774

Luxembourg

44

8

69

172

36

329

Netherlands

362

64

184

137

8

755

Austria

219

15

97

89

10

430

Portugal

289

125

128

201

28

771

Finland

215

112

144

120

7

598

Sweden

261

96

116

120

5

598

United Kingdom

773

173

248

288

9

1491

Others

15

48

4

9

1

77

Total

8 045

1 724

4 414

6 259

724

21 166

---
MISCELLANEOUS DISMISSALS

99-1248.

#### N. Olmsted Golf Course, Inc. v. Cuyahoga Cty. Bd. of Revision.

Board of Tax Appeals, No. 97-D-341. This cause is pending before the court as an appeal from the Board of Tax Appeals. Upon consideration of appellant’s application for dismissal,

IT IS ORDERED by the court that the application for dismissal be, and hereby is, granted.

ACCORDINGLY, IT IS FURTHER ORDERED by the court that this cause be, and hereby is, dismissed.
II 

Calendar No. 169 

114TH CONGRESS 

1ST SESSION S. 1881 

To prohibit Federal funding of Planned Parenthood Federation of America. 

IN THE SENATE OF THE UNITED STATES 

JULY 28, 2015 

Mrs. ERNST (for herself, Mr. MCCONNELL, Mr. PAUL, Mr. LANKFORD, Mr. 

BLUNT, Mr. CORNYN, Mrs. FISCHER, Mr. SCOTT, Mr. ISAKSON, Mr. 

COATS, Mr. INHOFE, Mr. BOOZMAN, Mr. ENZI, Mr. JOHNSON, Mr. 

THUNE, Mr. SASSE, Mr. BARRASSO, Mr. ROBERTS, Mr. DAINES, Mr. 

CRUZ, Mr. PERDUE, Mr. BURR, Mr. COTTON, Mr. MCCAIN, Mr. CASSIDY, Mr. PORTMAN, Mr. TILLIS, Mr. RUBIO, Mr. VITTER, Mr. ROUNDS, 

Mr. WICKER, Mr. CRAPO, and Mr. LEE) introduced the following bill; 

which was read the first time 

JULY 29, 2015 

Read the second time and placed on the calendar 

A BILL 

To prohibit Federal funding of Planned Parenthood 

Federation of America. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. FINDINGS. 

4 Congress finds as follows: 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•S 1881 PCS

1 (1) State and county health departments, com2 munity health centers, hospitals, physicians offices, 

3 and other entities currently provide, and will con4 tinue to provide, health services to women. Such 

5 health services include relevant diagnostic laboratory 

6 and radiology services, well-child care, prenatal and 

7 postpartum care, immunization, family planning 

8 services including contraception, sexually trans9 mitted disease testing, cervical and breast cancer 

10 screenings, and referrals. 

11 (2) Many such entities provide services to all 

12 persons, regardless of the person’s ability to pay, 

13 and provide services in medically underserved areas 

14 and to medically underserved populations. 

15 (3) All funds no longer available to Planned 

16 Parenthood will continue to be made available to 

17 other eligible entities to provide women’s health care 

18 services. 

19 SEC. 2. PROHIBITION. 

20 (a) IN GENERAL.—Notwithstanding any other provi21 sion of law, no Federal funds may be made available to 

22 Planned Parenthood Federation of America, or to any of 

23 its affiliates, subsidiaries, successors, or clinics. 

24 (b) RULES OF CONSTRUCTION.—Nothing in this Act 

25 shall be construed to— 

mstockstill on DSK4VPTVN1PROD with BILLS

3 

•S 1881 PCS

1 (1) affect any limitation contained in an appro2 priations Act relating to abortion; or 

3 (2) reduce overall Federal funding available in 

4 support of women’s health. 

mstockstill on DSK4VPTVN1PROD with BILLS

Calendar No. 169 

114TH CONGRESS 

1ST SESSION S. 1881 

A BILL 

To prohibit Federal funding of Planned Parenthood 

Federation of America. 

JULY 29, 2015 

Read the second time and placed on the calendar 

mstockstill on DSK4VPTVN1PROD with BILLS